14.09
前日終値:
$13.63
開ける:
$13.67
24時間の取引高:
22,072
Relative Volume:
0.48
時価総額:
$37.76M
収益:
-
当期純損益:
$-58.52M
株価収益率:
-6.7416
EPS:
-2.09
ネットキャッシュフロー:
$-45.03M
1週間 パフォーマンス:
+34.06%
1か月 パフォーマンス:
+36.14%
6か月 パフォーマンス:
+2,920%
1年 パフォーマンス:
+1,104%
Nextcure Inc Stock (NXTC) Company Profile
名前
Nextcure Inc
セクター
電話
240-399-4900
住所
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
NXTC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NXTC
Nextcure Inc
|
14.09 | 46.18M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-07 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2022-11-04 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | 開始されました | Ladenburg Thalmann | Buy |
| 2021-03-05 | アップグレード | Truist | Hold → Buy |
| 2021-01-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-07-16 | アップグレード | The Benchmark Company | Hold → Buy |
| 2020-07-13 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2020-07-13 | ダウングレード | SunTrust | Buy → Hold |
| 2020-06-01 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2020-05-26 | 開始されました | JMP Securities | Mkt Outperform |
| 2020-03-24 | 開始されました | The Benchmark Company | Buy |
| 2020-03-02 | 開始されました | ROTH Capital | Buy |
| 2020-01-13 | 開始されました | SunTrust | Buy |
| 2019-12-05 | 開始されました | Needham | Buy |
| 2019-11-26 | 開始されました | BTIG Research | Buy |
| 2019-07-09 | 開始されました | BofA/Merrill | Buy |
| 2019-06-03 | 開始されました | Morgan Stanley | Overweight |
| 2019-06-03 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Nextcure Inc (NXTC) 最新ニュース
NextCure files for offering of up to 2.52 million shares of common stock by selling stockholdersSEC filing - MarketScreener
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference - The Globe and Mail
NextCure (Nasdaq: NXTC) in fireside chat at Piper Sandler 37th Healthcare Conference - Stock Titan
NextCure Raises $21.5M in Private Placement - MSN
Will NextCure Inc. stock maintain momentum in 2025Trade Entry Summary & Reliable Trade Execution Plans - newser.com
Can NextCure Inc. stock sustain market leadershipQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
How currency fluctuations impact NextCure Inc. stockEarnings Overview Report & Precise Buy Zone Tips - newser.com
How NextCure Inc. stock reacts to inflationary pressuresJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
FY2025 EPS Estimates for NextCure Boosted by HC Wainwright - Defense World
NextCure Inc. recovery potential after sell offMarket Weekly Review & Fast Entry High Yield Stock Tips - newser.com
Will NextCure Inc. stock gain from lower inflationProfit Target & AI Enhanced Trading Alerts - newser.com
Evaluating NextCure Inc. with trendline analysisEarnings Growth Report & Real-Time Volume Analysis - newser.com
Comparing NextCure Inc. in custom built stock radarsJuly 2025 Sector Moves & Low Volatility Stock Recommendations - newser.com
A activityJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
NextCure secures $21.5 million in private placement to extend cash runway - Investing.com Canada
NextCure, Inc. Secures $21.5 Million in Private Placement, Extending Cash Runway into First Half of 2027 - Quiver Quantitative
NextCure (Nasdaq: NXTC) PIPE Extends Runway to 1H 2027 Ahead of 2026 ADC POC Data - Stock Titan
How to integrate NextCure Inc. into portfolio analysis toolsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
How institutional ownership impacts NextCure Inc. stockBond Market & Verified Momentum Stock Watchlist - newser.com
Predicting NextCure Inc. trend using moving averagesRisk Management & Safe Entry Zone Identification - newser.com
Has NextCure Inc. found a price floorStock Surge & Long-Term Safe Investment Plans - newser.com
NextCure raises $21.5 million in private placement to fund ADC programs - Investing.com Canada
How sentiment analysis helps forecast NextCure Inc.Quarterly Performance Summary & Accurate Technical Buy Alerts - newser.com
NextCure Shares Jump 15% After Private Placement Announcement - Nasdaq
NextCure Raises $21.5M to Extend Runway and Advance ADC Programs - BioBuzz
NextCure raises $21.5 million in private placement to fund ADC programs By Investing.com - Investing.com South Africa
NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules - The Manila Times
NextCure (NASDAQ: NXTC) announces $21.5M private placement to extend runway into 2027 - Stock Titan
Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect? - Finviz
Why NextCure Inc. stock is favored by top institutions2025 Earnings Surprises & Capital Efficiency Focused Strategies - newser.com
NextCure, Inc. announced that it expects to receive $21.500024 million in funding - MarketScreener
Nextcure Inc (NXTC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):